乳腺癌合并甲状腺癌1例诊治体会
Therapeutic Experience of Breast Cancer with Thyroid Cancer: 1 Case Report
摘要: 乳腺癌是女性最常见的恶性肿瘤之一,发病率约占全身各种恶性肿瘤的7%~10%,严重影响女性的身心健康,甚至威胁生命。甲状腺癌是最常见的甲状腺恶性肿瘤,约占全身恶性肿瘤的1%,女性发病较多,男女发病比例为1:2~1:4。近年来,尽管乳腺癌与甲状腺癌的发病率有逐渐上升趋势,但乳腺癌同时合并甲状腺癌者却很少见。本文结合我们对一例乳腺癌合并甲状腺癌患者的精准诊治体会,深入探讨其发生机制及诊治原则,以期提高其诊治效果,避免漏诊漏治。
Abstract: Breast cancer is one of the most common malignant tumors in women, with the incidence of about 7%~10% of all kinds of malignant tumors in the whole body, which seriously affects the physical and mental health of women, and even threatens her life. Thyroid cancer is the most common malignancy of thyroid, which accounts for about 1% of malignant tumors in the whole body, and occurs more frequently in females than males, with the incidence of male to female for 1:2 to 1:4. In recent years, although the incidence of breast cancer and thyroid cancer has been increasing, it is rare that breast cancer is combined with thyroid cancer. Based on our ex-perience of the accurate diagnosis and treatment of one patient with breast cancer combined with thyroid cancer, the pathophysiological mechanism and therapeutic principle are discussed, so as to improve its curative effect, and to avoid missed diagnosis and omitted treatment.
文章引用:朱明文, 张宗明, 林方才, 刘立民, 邓海, 张翀, 于宏伟, 刘卓, 万柏江, 杨海燕, 宋蒙蒙, 赵月. 乳腺癌合并甲状腺癌1例诊治体会[J]. 外科, 2018, 7(3): 85-89. https://doi.org/10.12677/HJS.2018.73014

参考文献

[1] [1] Fante, R., Roncucci, L., Di Gregorio, C., et al. (1996) Frequency and Clinical Features of Multiple Tumors of the Large Bowel in General Population and in Patients with Hereditary Colorectal Carcinoma. Cancer, 77, 2013-2021. [Google Scholar] [CrossRef
[2] Warren, S. and Gates, O. (1932) Multiple Primary Malignant Tumors, a Survey of the Literature and a Statistical Study. American Journal of Cancer, 16, 1358-1363.
[3] Subramanian, S., Goldstein, D.P., Parlea, L., et al. (2007) Second Primary Malignancy Risk in Thyroid Cancer Survivors: A Systematic Review and Meta-Analysis. Thyroid, 17, 1277-1288. [Google Scholar] [CrossRef] [PubMed]
[4] An, J.H., Hwangbo, Y., Ahn, H.Y., et al. (2015) A Possible Association between Thyroid Cancer and Breast Cancer. Thyroid, 25, 1330-1338. [Google Scholar] [CrossRef] [PubMed]
[5] Zhang, L., Wu, Y., Liu, F., et al. (2016) Characteristics and Sur-vival of Patients with Metachronous or Synchronous Double Primary Malignancies: Breast and Thyroid Cancer. Oncotarget, 7, 52450-52459. [Google Scholar] [CrossRef] [PubMed]
[6] Beatson, G. (1896) On the Treatment of Inoperable Cases of Carcinoma of the Mamma Suggestions for a New Method of Treatment, with Illustrative Cases. Lacent, 2, 104-110.
[7] Nielsen, S.M., White, M.G., Hong, S., et al. (2016) The Breast-Thyroid Cancer Link: A Systematic Review and Meta Analysis. Cancer Epidemiology, Biomarkers & Prevention, 25, 231-238. [Google Scholar] [CrossRef
[8] Yane, K., Kitahori, Y., Konishi, N., et al. (1994) Ex-pression of the Estrogen Receptor in Human Thyroid Neoplasms. Cancer Letters, 84, 59-66. [Google Scholar] [CrossRef] [PubMed]
[9] Rajoria, S., Suriano, R., Shanmugam, A., et al. (2010) Metastatic Phenotype Is Regulated by Estrogen in Thyroid Cells. Thyroid, 20, 33-41. [Google Scholar] [CrossRef] [PubMed]
[10] Prinzi, N., Baldini, E., Sorrenti, S., et al. (144) Prevalence of Breast Cancer in Thyroid Diseases: Results of a Cross-Sectional Study of 3,921 Patients. Breast Cancer Research and Treatment, 2014, 683-688. [Google Scholar] [CrossRef] [PubMed]
[11] Hall, L.C., Salazar, E.P., Kane, S.R., et al. (2008) Effects of Thyroid Hormones on Human Breast Cancer Cell Proliferation. The Journal of Steroid Biochemistry and Molecular Biology, 109, 57-66. [Google Scholar] [CrossRef] [PubMed]
[12] Micali, S., Bulotta, S., Puppin, C., et al. (2014) Sodium Iodide Symporter (NIS) Inextrathyroidal Malignancies: Focus on Breast and Urological Cancer. BMC Cancer, 14, 303. [Google Scholar] [CrossRef] [PubMed]
[13] Ryan, J., Curran, C.E., Hennessy, E., et al. (2011) The Sodium Iodide Sym-Porter (NIS) and Potential Regulators in Normal, Benign and Malignant Human Breast Tissue. PLoS ONE, 6, e16023. [Google Scholar] [CrossRef] [PubMed]
[14] Chatterjee, S., Malhotra, R., Varghese, F., et al. (2013) Quantitative Immunohistochemical Analysis Reveals Association between Sodiumiodide Symporter and Estrogen Receptor Expression in Breast Cancer. PLoS ONE, 8, e54055. [Google Scholar] [CrossRef] [PubMed]
[15] 胡早秀, 赵永和, 陈亚娟. 乳腺癌再发甲状腺癌与单发甲状腺癌ER表达的研究[J]. 诊断病理学杂志, 2016, 23(2): 124-126.